Personalised Medicine testing for solid tumours

The treatment and management of cancer is increasingly dependent on complex molecular diagnostics to ensure that patients have access to the most effective, targeted therapies.

  • Metastatic colorectal cancer
  • Non-small cell lung cancer
  • Melanoma
  • Gastro-intestinal stromal tumours

These tests are also available to customers in support of clinical trials and research projects. NewGene also works closely with the NHS and pharmaceutical companies on the validation of novel biomarkers and the development of diagnostic tests for personalised medicine to ensure access to leading clinical services.

Quick glance gene list

KRAS NRAS BRAF EGFR cKIT PDGFRA
Metastatic colorectal cancer
Non-small cell lung cancer
Melanoma
Gastro-intestinal stromal tumours

Overview of the MAPK pathway

Click here to view a Wikipedia page which contains greater detail on the MAP kinase signalling cascade and its importance in cancer.

Contact us

NewGene Limited
Bioscience Building
International Centre for Life
Newcastle upon Tyne
NE1 4EP, UK

Tel: +44 (0)191 242 1923
Fax: +44 (0)191 241 8799
Email: info@newgene.org.uk

Click here for location map

Mon – Fri 08:30 to 17:00, closed Bank Holidays

An ISO 15189 accredited Medical Laboratory company

NewGene Limited | Company Number: 06735445

Technology Partners

Agilent Technologies

Agena Bioscience

Illumina

Sophia Genetics

Qiagen

Promega

Enquiry form